Q4 2010

Filed Mar 11, 2011 · 10-K · 70 days after period end · 0000950123-11-024871

Q4 2010 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net income—

EPS, diluted—Not derived. Share counts vary by quarter.

Operating Cash Flowderived-$686,440—

Free Cash Flowderived-$952,298

Same quarter

no prior Q4 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Dec 31, 2010 · filed Mar 11, 2011 · 70 d after period end

Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR